Melanoma Clinical Trial

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria

Pathologically-proven diagnosis of melanoma.
Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Exclusion criteria

Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
Any patient unable or unwilling to provide consent.

Study is for people with:

Melanoma

Estimated Enrollment:

3000

Study ID:

NCT01205815

Recruitment Status:

Recruiting

Sponsor:

Vanderbilt-Ingram Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Vanderbitl-Ingram Cancer Center
Nashville Tennessee, , United States More Info
Vanderbilt-Ingram Service for Timely Access
Contact
800-811-8480
Douglas Johnson, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

3000

Study ID:

NCT01205815

Recruitment Status:

Recruiting

Sponsor:


Vanderbilt-Ingram Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.